CBD, for now, should not be subject to international drug scheduling, a World Health Organization committee determined in an initial review of the cannabis compound. WHO’s Expert Committee on Drug Dependence on Wednesday released findings and scheduling recommendations for more than a … Read More
The post World Health Organization: Initial review of CBD doesn’t warrant scheduling appeared first on Dagga Magazine.